Literature DB >> 24581920

Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine).

Nathan D Wong1, Christopher Patao2, Shaista Malik2, Uchenna Iloeje3.   

Abstract

Type 2 diabetes mellitus (T2DM) carries significant risks for coronary heart disease (CHD). We examined the potential US population impact of single and composite risk factor control. Among US adults with diagnosed T2DM aged≥30 years in the National Health and Nutrition Examination Survey 2007 to 2012, we assessed CHD events preventable using the United Kingdom Prospective Diabetes Study CHD risk engine. We examined in all those not at goal the impact of statistical control of smoking, glycated hemoglobin, systolic blood pressure, and total and high-density lipoprotein cholesterol, according to the predefined criteria setting risk factors at different levels of control representing (1) "All to Goal," (2) at "Nominal Control," or (3) at "Aggressive Control." Preventable CHD events represented the difference between the number of events estimated from the control of these risk factors versus current levels of the risk factors. Of 606 men (representing 6.2 million) and 603 women (6.3 million) with DM and no previous CHD, 1.3 million men and 0.7 million women would develop a CHD event within 10 years if left uncontrolled. Controlling all risk factors to goal was projected to prevent 35% and 45% of CHD events in men and women, respectively. Nominal risk factor control was projected to prevent 36% and 38% and aggressive control 51% and 61% of CHD events, respectively. In conclusion, a significant proportion of CHD events in adults with T2DM could be prevented from composite control of risk factors often not at goal.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24581920     DOI: 10.1016/j.amjcard.2013.12.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Nathan D Wong; Yanglu Zhao; Ruben G W Quek; Roger S Blumenthal; Matthew J Budoff; Mary Cushman; Parveen Garg; Veit Sandfort; Michael Tsai; J Antonio G Lopez
Journal:  J Clin Lipidol       Date:  2017-06-30       Impact factor: 4.766

2.  Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus.

Authors:  A E Berezin; A A Kremzer; T A Samura; T A Berezina; P Kruzliak
Journal:  J Endocrinol Invest       Date:  2015-04-28       Impact factor: 4.256

3.  Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.

Authors:  Nathan D Wong; Yanglu Zhao; Rohini Patel; Christopher Patao; Shaista Malik; Alain G Bertoni; Adolfo Correa; Aaron R Folsom; Sumesh Kachroo; Jayanti Mukherjee; Herman Taylor; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2016-03-29       Impact factor: 19.112

4.  Effect of risk factor control on simulated coronary heart disease events.

Authors:  Jennifer M Cooper; Neda Laiteerapong
Journal:  Am J Cardiol       Date:  2014-05-17       Impact factor: 2.778

5.  Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.

Authors:  Eric Yuk Fai Wan; Colman Siu Cheung Fung; Esther Yee Tak Yu; Weng Yee Chin; Daniel Yee Tak Fong; Anca Ka Chun Chan; Cindy Lo Kuen Lam
Journal:  J Am Heart Assoc       Date:  2017-08-17       Impact factor: 5.501

6.  Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardiovascular Disease.

Authors:  Thilak Weerarathna; Gayani Liyanage; Meththananda Herath; Miyuru Weerarathna; Isuru Amarasinghe
Journal:  Biomed Res Int       Date:  2018-12-26       Impact factor: 3.411

7.  Development and Primary Evaluation of a Smartphone Application for Blood Glucose Control in Hospitalized Patients.

Authors:  Rezvan Salehidoost; Elaheh Mirtallaee; Mansour Siavash
Journal:  Adv Biomed Res       Date:  2019-07-25

8.  Low-risk Lifestyle and Health Factors and Risk of Mortality and Vascular Complications in Chinese Patients With Diabetes.

Authors:  Zhijia Sun; Yizhen Hu; Canqing Yu; Yu Guo; Yuanjie Pang; Dianjianyi Sun; Pei Pei; Ling Yang; Yiping Chen; Huaidong Du; Jianrong Jin; Sushila Burgess; Alex Hacker; Junshi Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

9.  Effects of Dietary Supplementation with Agaricus sylvaticus Schaeffer on Glycemia and Cholesterol after Streptozotocin-Induced Diabetes in Rats.

Authors:  Marcelo Betti Mascaro; Cristiane Miranda França; Kamilla F Esquerdo; Marx A N Lara; Nilsa S Y Wadt; Erna E Bach
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-26       Impact factor: 2.629

10.  Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.

Authors:  Narges Safai; Bendix Carstensen; Henrik Vestergaard; Martin Ridderstråle
Journal:  BMJ Open       Date:  2018-03-17       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.